pSLCAR-CD19-CD3z Citations (3)
Originally described in: A High-Throughput Method for Characterizing Novel Chimeric Antigen Receptors in Jurkat Cells.Bloemberg D, Nguyen T, MacLean S, Zafer A, Gadoury C, Gurnani K, Chattopadhyay A, Ash J, Lippens J, Harcus D, Page M, Fortin A, Pon RA, Gilbert R, Marcil A, Weeratna RD, McComb S Mol Ther Methods Clin Dev. 2020 Jan 31;16:238-254. doi: 10.1016/j.omtm.2020.01.012. eCollection 2020 Mar 13. PubMed Journal
Articles Citing pSLCAR-CD19-CD3z
| Articles |
|---|
| Titering of Chimeric Antigen Receptors on CAR T Cells enabled by a Microfluidic-based Dosage-Controlled Intracellular mRNA Delivery Platform. Chen YH, Jiang R, Lee AP. bioRxiv [Preprint]. 2023 Mar 15:2023.03.14.532624. doi: 10.1101/2023.03.14.532624. PubMed |
| Ultraviolet metasurface-enabled flat-top beam shaping with size preservation uniformity and broadband robustness. Li W, Li J, Zhao T, Li Y, Wang C, Li P, Zheng Z, Ding F, Li H. Sci Rep. 2026 Apr 2;16(1):15687. doi: 10.1038/s41598-026-45434-z. PubMed |
| A regenerative and programmable iPSC-derived platelet platform for universal drug delivery and immunotherapy. Wang L, Zhang P, Wu C, Yu S, Ji Y, Liu J, Yuan H, Zhang K, Qiu Y, Zhu F. Trends Biotechnol. 2026 Jun 19:S0167-7799(26)00229-5. doi: 10.1016/j.tibtech.2026.05.017. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.